Corient Private Wealth’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $700K | Buy |
26,430
+13,214
| +100% | +$350K | ﹤0.01% | 1607 |
|
2025
Q1 | $319K | Buy |
13,216
+797
| +6% | +$19.2K | ﹤0.01% | 1815 |
|
2024
Q4 | $500K | Sell |
12,419
-396
| -3% | -$15.9K | ﹤0.01% | 1617 |
|
2024
Q3 | $811K | Buy |
12,815
+486
| +4% | +$30.8K | ﹤0.01% | 1482 |
|
2024
Q2 | $654K | Sell |
12,329
-9,971
| -45% | -$529K | ﹤0.01% | 1502 |
|
2024
Q1 | $1.83M | Buy |
22,300
+828
| +4% | +$67.9K | ﹤0.01% | 1059 |
|
2023
Q4 | $400K | Buy |
+21,472
| New | +$400K | ﹤0.01% | 1725 |
|